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WHO: World Health OrganizationINTRODUCTION
Cutaneous infiltration in the skin is rare in patients
with preeB-cell acute lymphoblastic leukemia
(preeB-ALL). We describe the case of a patient
with leukemia cutis (LC) who presented with nod-
ules predominantly on the face. To our knowledge,
there are no previously reported cases of LC in adults
with preeB-ALL.
CASE REPORT
A 46-year-old man, who was a farmer without
a significant medical history, presented to the
emergency department for acute lower chest pain
and a 3 month history of a 2- 3 1-cm dome-shaped,
indurated, erythematous-purplish nodule on the
nose surrounded by atrophic and telangiectatic
skin. He also complained of a 5 kg weight loss in
the last month. He also had forehead and left forearm
nodules that were larger, firm in consistency, and
homogeneously erythematous (Fig 1). All lesions
were asymptomatic. Examination of his oral cavity,
regional lymph nodes, and the rest of his skin was
unremarkable. Blood tests found a total leukocyte
count of 17,700/mm3, with 3,600 lymphocytes
without blasts, 12,900/mm3 neutrophils, 800/mm3
monocites, 300/mm3 eosinophils and 100/mm3
basophils, serum hemoglobin of 9.3 g/dL, platelet
count of 35,000/mm3, and lactic acid dehydrogenase
level of 1,569 (IU/L). The first diagnostic impression
was cutaneous lymphoma, and a skin biopsy
was performed. The histopathologic examination
of the skin biopsy specimen found an atrophic
epidermis and a massive proliferation of leukemic
cells with marked nuclear pleomorphism cha-
racterized by cerebriform nuclei, atypical mitoses,the Dermatology Department, Hospital Central Dr. Ignacio
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stanju@yahoo.com.microvacuolated cytoplasm within the papillary, and
reticular dermis surrounding the vessels as well as
cutaneous appendages without vasculitis (Fig 2).
Immunohistochemical examination found
neoplastic cells positive for CD20 and CD79, indi-
cating an infiltrate of B-cell precursors (Fig 3).
Additional immunolabeling of lesions by flow
cytometry was positive for CD10, CD20, and CD19
and negative for surface immunoglobulin. This
pattern was compatible with preeB-ALL according
to the current World Health Organization (WHO)
Classification of Tumours of Haematopoietic and
Lymphoid Tissues.1 The bone marrow aspirate
found 30% of blasts in the smear, and flow cytometric
analysis found the expression of CD20, CD22, and
CD79a as markers of B cells and the CD19 antigen as
a primitive precursor of B cells. There was no
expression of T-cell antigens such as CD2, CD3,
CD5, or CD7. According to the WHO classification
system, the patient presented features of poor
prognosis, such as age older than 40 years and an
immature cell immunophenotype.2
After the diagnosis, he received the induction
phase of treatment for ALL in adults with
hyperfractionated cyclophosphamide, vincristine,
doxorubicin, and dexamethasone. Cutaneous le-
sions evolved with partial involution, but the
patient’s general condition worsened after 3 months.JAAD Case Reports 2015;1:364-7.
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Fig 1. Leukemia cutis. A, A 2- 3 1-cm, dome-shaped, indurated, erythematous-purplish
nodule in the nose surrounded by atrophic and telangiectatic skin. B, A 5- 3 3-cm
asymptomatic erythematous firm nodule on the left forearm.
Fig 2. A, Massive proliferation of leukemic cells invading papillary and reticular dermis.
B, Marked nuclear pleomorphism characterized by cerebriform nuclei, atypical mitoses, and
microvacuolated cytoplasm. (A and B, Hematoxylin-eosin stain; original magnifications:
A, 3100; B, 3400.)
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follow-up.DISCUSSION
LC is an extramedullary manifestation of leuke-
mia, defined as cutaneous infiltration by neoplastic
leukemic cells resulting in clinically recognizable
skin lesions.3 The clinical and morphologic features
of LC are variable and can present as violaceous,
erythematous, or hemorrhagic nodules, papules,
vesicles, bullae, or plaques of varying sizes.3 LC is
more frequently associated with acute myeloid leu-
kemia than with ALL.4 The prevalence of LC in ALL is
1% to 3%, but it is rare in cases of preeB-ALL.5Apparently, there have only been 2 cases reported
in the literature related to LC and preeB-ALL. One
patient presented LC in the absence of systemic
leukemia and exhibited a solitary, dome-shaped,
erythematous, indurated nodule on his left cheek.6
Another case was in a child who manifested dissem-
inated nodules that became edematous, pruritic, and
erythematous after stroking them (Darier’s sign).7
This case is unique, as it may represent, to our
knowledge, the first reported case of LC in an adult
with preeB-ALL. This subtype of leukemia is
clinically and morphologically indistinguishable
from the classic ALL, but differs in terms of the
surface antigens expressed on cells, whose presence
confers a different prognostic value in this setting.
Fig 3. A, Immunohistochemical study that shows leukemic cells positive for CD20 and B, cells
positive for CD79. These markers are usually positive in preeB-ALL. (Avidin-biotin-peroxidase
complex staining. Original magnifications: A and B, 3200.)
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median survival rate of 14 months after diagnosis.6,8
On clinical examination we considered a natural
killer T-cell lymphoma because of location and
morphology; however, immunohistochemical exam-
ination found neoplastic cells positive for CD20 and
CD79, indicating an infiltrate of B-cell precursors.
Additionally, lymphoblastic lymphoma was ruled out
after imaging studies demonstrated no evidence of
lymph nodes or mass lesions and based on the
morphologic characteristics of bone marrow
cellularity ([30% of blasts cells with a prominent
nucleolus).
PreeB-ALL accounts for approximately 2% of
acute leukemias; it occurs most frequently in child-
hood but can also be seen in adulthood, with an
overall median age of 40 years. Hispanics have the
highest incidence of any ethnic group, where
hepatomegaly, splenomegaly, and lymphade-
nopathy can be seen in up to half of adults on
presentation. In these cases, the central nervous
system is the most common extramedullary site
involved.8 Cutaneous infiltration is more frequently
implicated in precursor T-cell lymphoblastic acute
leukemias, but in preeB-ALL, this phenomenon is a
rarity, and skin involvement would be the expres-
sion of advanced disease.9 According to the WHO
classification for hematologic neoplasms, patient
age older than 40 years, immunophenotype and
genetic features such as traslocations, numerical
changes, and IKZF gene expression are poor
prognosis factors in acute leukemias. LC in
adults with ALL usually predicts an accelerated
disease progression with worse prognosis, as studiesindicate a survival rate of approximately of 15% at
6 months after its recognition.10
LC is an infrequent finding in ALL, but should
always be considered in the differential diagnosis of
asymptomatic rapidly growing cutaneous nodules,
especially if they are associated with hematologic
alterations. Thus, the suspicion and early interven-
tion of dermatologists, assisted by further histologic
studies of cutaneous lesions, plays an important role
in diagnosis, discriminating between variants and in
establishing early treatment.
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